TOP STORIES

• ORGANIZATION JPMA Compliance Committee to Decide Penalties for Novartis for Diovan Case as Requested by Dr Teshirogi
  October 3, 2013

• BUSINESS Another Administrative Action Taken Against MTPC on Medway Injection; 3rd in 4 Years
  October 2, 2013

• REGULATORY Interim Report of Diovan Panel Fails to Lay Bare Who Altered Data, for What Purpose
  October 1, 2013

• BUSINESS Amgen Astellas BioPharma to Go on Stream Oct. 1; JV Chief Takahashi Eager to Make It a “Category Leader”
  September 30, 2013

• REGULATORY Japan Health Minister Meets Exec of Swiss Novartis, Seeks Cooperation in Diovan Probe
  September 27, 2013

• REGULATORY JPWA Seeks Generic Name Listing for Wider Range of Generics
  September 27, 2013

• BUSINESS 3 Pharma Groups Demand Permanent Introduction of Premium at CSIMC; Healthcare Rep Still Wary
  September 26, 2013

• BUSINESS Daiichi Sankyo Dogged by Renewed Quality Woes at Ranbaxy; FDA Mute on Details
  September 26, 2013

• ACADEMIA National University Hospital Council Urges Immediate Check-Up on Hospital’s Clinical Research Systems
  September 25, 2013

• BUSINESS Unique Marketing System Jacks Up Profits at Vital KSK; Customer-by-Customer Cost Analyses Lend Support
  September 24, 2013

• REGULATORY FTC’s Legal Intervention in Diovan Issue Possible, but Only with New Facts: Lawyer
  September 20, 2013

• BUSINESS MTPC Completes Acquisition of Medicago, Now Ready to Bolster Vaccine Development
  September 20, 2013

• BUSINESS Daiichi Sankyo, Mitsubishi UFJ Capital Establish New Fund to Support Ventures in Japan
  September 19, 2013

• BUSINESS Demand Growing for Transdermal Patches in Graying Japan, Drug Makers Gear Up for Development
  September 18, 2013

• REGULATORY MHLW Plans to Establish Ethics Committee Certification System to Improve the Quality of Clinical Research
  September 18, 2013

• BUSINESS Takeda Grants Arbor Exclusive Rights for Edarbi Family of Products in US
  September 17, 2013

• ORGANIZATION Transparency Guidelines: JPMA Says Requested Viewers’ Names, Affiliations Could Be Checked before Disclosing Individual Payment Information
  September 13, 2013

• BUSINESS Nippon Kayaku’s Filing of Remicade Biosimilar Heralds Age of Major Biologic Follow-Ons
  September 12, 2013

• REGULATORY PMDA Eyes Mandatory Electronic Filings for NDA Clinical Trial Data from FY2016
  September 11, 2013

• ACADEMIA Use Double-Blind Method to Regain Confidence in Japanese Clinical Trials: Dr Yui of Kyoto Univ. Hospital
  September 10, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 210
• 211
• 212
• 213
• 214
• 215
• 216
• 217
• 218
• …
• Next ›
• 最終 »